| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.17 | 0.0007 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |